Cardiovascular disease (CVD) risk assessment tools such as the Framingham Risk
Functions, often called Framingham Risk Scores, are common in the evaluation of the CVD …

Background: People living with HIV (PLWHIV) have a 2-fold higher risk of having a
cardiovascular event than HIV-negative individuals. Objective: The objective of this article is …

Background Cardiovascular disease (CVD) risk prediction tools are often applied to
populations beyond those in which they were designed when validated tools for specific …

Since the advent of highly active antiretroviral therapy (HAART), studies have been
conflicting regarding weight information among patients with HIV. We performed a …

The objectives of this study were to determine the epidemiology and correlates of
cardiovascular disease (CVD) risk among Ugandans on first-line antiretroviral therapy …

In order to limit the disease burden and economic costs associated with the COVID-19
pandemic, it is important to understand how effective and widely distributed a vaccine must …

Objectives The aim of the study was to compare the predictions of five popular
cardiovascular disease (CVD) risk prediction models, namely the Data Collection on …

Objectives HIV‐infected patients show an increased cardiovascular disease (CVD) risk
resulting, essentially, from metabolic disturbances related to chronic infection and …

Background Anti-retroviral treatment has improved mortality of human immunodeficiency
virus (HIV) infected patients, which is offset by an increasing burden of cardiovascular …

Background: Antiretroviral therapy improved the survival of patients with human
immunodeficiency virus (HIV) infection. With increased life expectancy, HIV-infected patients …